<--- Back to Details
First PageDocument Content
TREAT-NMD / Clinical research / Pharmaceutical industry / Spinal muscular atrophy / Disease registry / Clinical trial / Duchenne muscular dystrophy / NMD / Council of European National Top Level Domain Registries / Medicine / Health / Medical research
Date: 2011-01-12 04:58:12
TREAT-NMD
Clinical research
Pharmaceutical industry
Spinal muscular atrophy
Disease registry
Clinical trial
Duchenne muscular dystrophy
NMD
Council of European National Top Level Domain Registries
Medicine
Health
Medical research

CHARTER_TREAT-NMD_Global_Database_Approved

Add to Reading List

Source URL: www.treat-nmd.eu

Download Document from Source Website

File Size: 120,47 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document